Fredun Pharmaceuticals Limited Q1 FY26 earnings call summary

Earnings call of 1 Aug 2025, summarised by AI from the filing.

Fredun Pharmaceuticals Q1 FY26 revenue up 52% to ₹1,19.86 cr, net profit up 64% to ₹6.77 cr; targets ₹800 cr plus revenue in 3-4 years.

Key takeaways

1. Guidance Targets ₹800 cr plus revenue and ₹90-plus cr PAT in 3 to 4 years.
2. Driver New age business with gross margins above 50% to drive profitability.

Original filing on BSE

Fredun Pharmaceuticals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (13 Aug 2026)
• Q4 FY26: Earnings call (10 Jun 2026)
• Q3 FY26: Earnings call (12 Feb 2026)
• Q2 FY26: Earnings call (11 Nov 2025)
• Q1 FY26: Earnings call (1 Aug 2025)
• Other events: Call transcript (6 Jun 2026), Strategy deck (10 Jun 2025), Strategy deck (10 Jun 2025)